Myosure Reach Tissue Removal Device 10-401FC

GUDID 25420045504537

The MyoSure Tissue Removal System is intended for hysteroscopic intrauterine resection procedures by a trained gynecologist to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.

Hologic, Inc.

Tissue morcellation system
Primary Device ID25420045504537
NIH Device Record Key48a75ec9-2ef1-4bf2-8a5a-3807e46502dc
Commercial Distribution StatusIn Commercial Distribution
Brand NameMyosure Reach Tissue Removal Device
Version Model Number10-401FC
Catalog Number10-401FC
Company DUNS018925968
Company NameHologic, Inc.
Device Count1
DM Exempttrue
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS115420045504530 [Primary]
GS125420045504537 [Package]
Contains: 15420045504530
Package: CARTON [1 Units]
In Commercial Distribution
GS135420045504534 [Package]
Package: BOX [3 Units]
In Commercial Distribution

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

HIHHYSTEROSCOPE (AND ACCESSORIES)

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2023-08-03
Device Publish Date2023-07-26

Devices Manufactured by Hologic, Inc.

15420045516991 - Aptima®2025-03-24 Aptima® SARS-CoV-2 Assay, 100 test, box 1 of 2 (2°C to 8°C box).
15420045517004 - Aptima®2025-03-24 Aptima® SARS-CoV-2 Assay, 100 test, box 2 of 2 (15°C to 30°C box).
15420045517035 - Aptima®2025-03-24 Aptima® SARS-CoV-2 Assay Controls Kit.
15420045517059 - Aptima®2024-12-27 Aptima® BV assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima® BV assay is an in vitro nucleic acid amplification test
15420045517066 - Aptima®2024-12-27 Aptima® BV assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima® BV assay is an in vitro nucleic acid amplification te
15420045517073 - Aptima®2024-12-27 Aptima® CV/TV assay, 250 test, box 1 of 2 (2°C to 8°C box). The Aptima® CV/TV assay is an in vitro nucleic acid amplificatio
15420045517080 - Aptima®2024-12-27 Aptima® CV/TV assay, 250 test, box 2 of 2 (15°C to 30°C box). The Aptima® CV/TV assay is an in vitro nucleic acid amplificat
15420045506411 - ATEC2024-10-24

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.